Mupirocin

   
Google
 
Web NewDrugInformation.com

Mupirocin


Drug - Mupirocin
The trade name of the product as shown on the labeling.

Dosage - OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Mupirocin
Multiple ingredients are in alphabetical order.

Strength - 2%
The potency of the active ingredient(s), Mupirocin. May repeat for multiple part products.

Applicant - CLAY PARK
The firm name holding legal responsibility for Mupirocin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 065123
The FDA assigned number to Mupirocin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Mupirocin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 7, 2003
The date Mupirocin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Mupirocin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Mupirocin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Clay Park Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Mupirocin.

Mupirocin